| Revenue growth | Consolidated +42% YoY; standalone +39% YoY. |
|---|---|
| Margins | Consolidated EBITDA margin 15.3% (+95 bps); standalone 18.6%. |
| Demand visibility | Substantial scale-up expected Q4 FY27; US electrolyte sourcing shift. |
| Management confidence | Upbeat; says full-year consolidated guidance on track. |
Growth
Consolidated revenue +42% to INR 296 Cr; EBITDA +51% to INR 45 Cr; PAT +144% to INR 8 Cr.
Outlook
Organolithium expansion, Patancheru 300 to 600 MTPA (INR 45 Cr). Neogen Ionics projects INR 1,795 Cr, completion Feb-Mar 2027.
Risks
Middle East conflicts, supply-chain friction, feedstock inflation; Dahej plant outage; higher interest and depreciation from capex.
Last quarter's promises, checked
Delivered
- Net debt INR 1,000–1,500 Cr → INR 1,095 Cr (= BEAT)
- Intl approvals 4 → 5 (= BEAT)
- Standalone EBITDA 18%±1.5 → 18.6% (= BEAT)
Partly delivered
- Electrolyte commissioning H1 → trial runs only (= PARTIAL)
- Supply to 4 approved customers → 2 (= PARTIAL)
- Battery FY27 INR 300 Cr → Q2 INR 37 Cr (= PARTIAL)
Missed
- Organolithium capex <INR 15 Cr → INR 45 Cr for 600 MTPA (= MISS)
- Dahej commercial start Q2 → outage flagged (= MISS)
- Operating leverage improve → fixed-cost absorption NIL (= MISS)
Investor Presentation filed with BSE, NSE: NEOGEN. Summary written with AI assistance from the document.
Neogen Chemicals Ltd: key numbers
- Share price
- ₹2,171.40
- Market cap
- ₹6,523 Cr
- Revenue (annual)
- ₹862.0 Cr
- Net profit (annual)
- ₹28.75 Cr
- P/E (TTM)
- 183.4×Sector 34.1×
- Promoter holding
- 48.31%-4.70% QoQ
- FII holding
- 4.13%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Neogen Chemicals Ltd
All →Neogen Chemicals Results Update
Neogen Chemicals issued its Q2 FY27 press release on unaudited results, showing higher year-on-year revenue and profit. Battery chemicals ramp-up and the QIP proceeds featured prominently.
Neogen Chemicals Debt & Borrowing: ₹500 Cr
Neogen Chemicals approved in-principle a Rs 500 Crore corporate guarantee for Neogen Morita's borrowings, subject to shareholder approval. The company reports no adverse impact.
- Value
- ₹500.0 Cr
Neogen Chemicals Capacity Expansion: ₹45 Cr Investment
Neogen Chemicals' board approved a capacity addition of 600 MT/PA with a Rs 45.00 Crore investment. Funding will come from internal accruals and debt.
- Value
- ₹45.00 Cr
- Execution
- By end of next financial year
- manufacturing capacity
- 600.0 MTPA
Neogen Chemicals Other Announcement
Neogen reports no deviation in QIP fund utilisation for the quarter ended September 30, 2026. This is a periodic utilisation report, not a new transaction.
Neogen Chemicals Q2 FY27 Results: Net Profit ₹8.2 Cr, Up 141.2% YoY
Neogen Chemicals Ltd reported revenue from operations of ₹296 Cr (+41.8% YoY) and net profit of ₹8.2 Cr (+141.2% YoY) for Q2 FY27.
- Key figure
- Net profit ₹8.2 Cr · +141.2% YoY
Neogen Chemicals Adverse Business Impact
Neogen Chemicals reports continued fire disruption at MPP3; replacement plant partly built with trial runs underway. Recognized damage totals ₹348.16 crore; production shifted to other sites.
- Value
- ₹348.2 Cr